Pro Medicus Limited (ASX:PME – Get Free Report) declared a interim dividend on Friday, February 14th,MarketIndexAU Dividends reports. Investors of record on Thursday, March 20th will be paid a dividend of 0.25 per share on Thursday, March 20th. This represents a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, February 26th. This is a positive change from Pro Medicus’s previous interim dividend of $0.18.
Pro Medicus Price Performance
The company has a quick ratio of 4.39, a current ratio of 5.98 and a debt-to-equity ratio of 1.10. The firm has a market capitalization of $29.16 billion, a PE ratio of 351.99, a price-to-earnings-growth ratio of 3.87 and a beta of 0.56.
Insider Activity
In other news, insider Sam Hupert sold 1,000,000 shares of Pro Medicus stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of A$256.73 ($163.52), for a total transaction of A$256,730,000.00 ($163,522,292.99). 51.20% of the stock is currently owned by corporate insiders.
Pro Medicus Company Profile
Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers Visage radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform.
Further Reading
- Five stocks we like better than Pro Medicus
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Technology Stocks Explained: Here’s What to Know About Tech
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- MarketBeat Week in Review – 02/10 – 02/14
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.